This federal contract award, with an ID of SPE2DB20D3505|SPE2DB25FT5Q2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,737.67, is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) with AmerisourceBergen, which has a potential value of $999,999,999 and runs through November 2026.
The award is for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a completion date of December 9, 2024. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for delivering the specified pharmaceutical product to support DLA's medical supply needs, particularly for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/7/25, 10:03 AM